Related Experiment Video
Updated: May 1, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Deletion of p18(INK4c) aggravates cisplatin-induced acute kidney injury
Liang Wang1, Wei Chen2, Yi Zhang2
1Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116021, P.R. China.
Abstract:
Protection of cyclin-dependent kinase inhibitors (CDKIs) has been demonstrated in acute kidney injury (AKI). However, previous studies on CDKIs have mainly focused on CIP/KIP family members, with INK4 family members rarely being investigated. This study investigated the behaviors of p18(INK4c) (p18) in cisplatin-induced AKI using p18 gene knockout mice (p18-/-). AKI was induced in p18-/- and wild-type (p18+/+) mice after a single cisplatin (12.5 mg/kg) intraperitoneal injection. Protection by p18 was identified by a comparison of survival, renal function and morphological injuries between p18-/- and p18+/+ mice. Further investigation of endoplasmic reticulum stress (ERS) was performed by western blot analysis in p18-/- and p18+/+ kidneys at day 3 after cisplatin injection. The results revealed that after cisplatin injection, the survival of p18-/- mice was significantly shorter than that of p18+/+ mice, accompanied by aggravated renal function and more severe morphological injuries. Deletion of p18 also significantly aggravated ERS in cisplatin-induced AKI. In conclusion, p18 exerts protective effects on cisplatin‑induced AKI, which may be associated with the effect of p18 on cell death pathways, such as the ERS pathway.
Insights
The INK4 family member p18 (INK4c) protects against acute kidney injury (AKI). Deleting p18 worsened kidney damage and survival in cisplatin-induced AKI, suggesting p18
Area of Science:
- Nephrology
- Molecular Biology
- Cellular Stress Response
Background:
- Cyclin-dependent kinase inhibitors (CDKIs) show protective effects in acute kidney injury (AKI).
- Research on CDKIs in AKI has primarily focused on CIP/KIP family members.
- The role of INK4 family members, specifically p18(INK4c) (p18), in AKI remains under-investigated.
Purpose of the Study:
- To investigate the role of p18(INK4c) in cisplatin-induced acute kidney injury (AKI).
- To evaluate the protective effects of p18 in a mouse model of AKI.
- To explore the association between p18 expression and endoplasmic reticulum stress (ERS) in AKI.
Main Methods:
- Utilized p18 gene knockout mice (p18-/-) and wild-type (p18+/+) littermates.
- Induced AKI via a single intraperitoneal injection of cisplatin (12.5 mg/kg).
- Assessed survival rates, renal function (e.g., serum creatinine, BUN), morphological kidney injuries, and endoplasmic reticulum stress markers (Western blot).
Main Results:
- Mice lacking p18 (p18-/-) exhibited significantly reduced survival rates compared to wild-type mice (p18+/+) following cisplatin administration.
- p18 deletion exacerbated renal function impairment and morphological damage in cisplatin-induced AKI.
- The absence of p18 significantly aggravated endoplasmic reticulum stress (ERS) in the kidneys of AKI mice.
Conclusions:
- p18(INK4c) exerts a protective role in cisplatin-induced acute kidney injury.
- The protective mechanism of p18 may involve the regulation of cell death pathways, particularly endoplasmic reticulum stress.
- These findings highlight p18 as a potential therapeutic target for AKI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

